The largest health insurance providers in the United States have reaffirmed their commitment to fully cover vaccinations, including COVID-19 and annual flu shots, that receive recommendations from a federal advisory panel. This announcement, made by America’s Health Insurance Plans (AHIP) on September 17, 2025, coincides with the upcoming meeting of the reformed Advisory Committee on Immunization Practices (ACIP), featuring new members appointed by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a known vaccine skeptic. The ACIP is responsible for providing expert guidance to the CDC on vaccination policies.
UCG/Universal Images Group via Getty Images
In a significant development for public health, the nation’s leading health insurance companies have asserted their continued coverage of vaccinations, which includes protections against COVID-19 and seasonal influenza. This commitment was highlighted in a statement from AHIP, which represents major health plans such as CVS Health’s Aetna, Humana, Cigna, Centene, and various Blue Cross and Blue Shield networks.
“Health plans are dedicated to ensuring accessible vaccine options for all,” AHIP stated. “Our coverage decisions for immunizations rely on rigorous, ongoing assessments of scientific and clinical data.” This pledge comes during a peak season when many Americans seek flu and COVID-19 vaccinations at local pharmacies, clinics, and healthcare providers.
The AHIP announcement brings clarity amid emerging concerns regarding the future of vaccine coverage, particularly in light of Secretary Kennedy’s new policies and the potential impact on long-standing vaccine protocols. AHIP’s member plans collectively provide health care coverage to over 200 million individuals across the country.
“Health plans will continue to cover all ACIP-recommended immunizations effective September 1, 2025, including updated COVID-19 and influenza vaccines, with no cost-sharing for patients until the end of 2026,” AHIP affirmed. “While operating in a complex regulatory environment, our evidence-based approach to immunizations remains unchanged.”
This commitment from health insurers serves their interests by safeguarding public health; preventing illnesses through vaccination can help avoid costly health complications and hospitalizations, ultimately easing the financial burden on both health plans and their members.
As the ACIP prepares to explore new eligibility criteria for COVID-19 booster shots, AHIP’s proactive stance is especially timely. Earlier this year, Secretary Kennedy controversially dismissed all 17 ACIP members, triggering a backlash from prominent medical organizations such as the American Medical Association and the American Academy of Pediatrics.
AHIP’s announcement has not gone unnoticed, even by critics of the health insurance industry’s past behavior. Dr. Robert Steinbrook, director of Public Citizen’s Health Research Group, remarked, “Though it is uncommon for us to commend health insurers, AHIP’s responsible actions suggest a potential for a rational approach toward immunizations.”
“By ensuring comprehensive coverage for all immunizations recommended by the ACIP as of September 1, 2025, including updated vaccine formulations, health plans anticipate and potentially mitigate the adverse effects of Secretary Kennedy’s newly appointed advisory panel in the coming months,” he added. “Health plans are ultimately fulfilling a role better suited for federal health agencies, prioritizing public health by maintaining and ensuring affordable access to vaccines,” Steinbrook concluded.
